Patent · US Active

Indolylmaleimide derivatives

US7786123B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Inventors

Key dates

Filing dateJul 7, 2009
Grant dateAug 31, 2010
Priority date
Expiry dateJul 7, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.